全球美容皮肤科市场 – 2029 年行业趋势及预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球美容皮肤科市场 – 2029 年行业趋势及预测

  • Medical Devices
  • Published Report
  • May 2022
  • Global
  • 350 页面
  • 桌子數: 220
  • 图号: 60

>全球美容皮肤科市场,按产品类型(药品和设备)、手术类型(微创和非侵入性)、治疗类型(面部治疗和身体治疗)、应用(皮肤嫩肤、皮肤重塑、皮肤紧致、脱毛、色素沉着和血管病变、纹身去除、疤痕、痤疮、色素异常、皮赘、牛皮癣、疣、多汗症、痣和雀斑等)、性别(女性和男性)、最终用户(医院、皮肤​​科诊所、外科中心、水疗诊所等)、分销渠道(直接招标和零售销售)划分 – 行业趋势和预测到 2029 年

美容皮肤科市场规模

市场定义

美容皮肤科是一种新颖且独特的皮肤科实践。它是一组用于改善个人外貌而非治疗潜在疾病的治疗方法。美容皮肤科涵盖的不同类型的治疗方法包括肉毒杆菌毒素注射、皱纹填充、微晶磨皮、抽脂、整形和激光换肤。美容皮肤科的主要目的是通过减少或消除瑕疵来改善人的外貌。这些瑕疵大部分与皮肤有关,尤其是面部,而一些治疗方法则针对身体和头发。

美容皮肤科市场概况

美容皮肤科市场趋势

市场分析和见解

美容皮肤科致力于解决皮肤和头发问题,使它们看起来更健康,甚至可以增强那些对自己的外表不满意的患者的自信。美容皮肤科已成为皮肤科领域的一个重要问题。美容皮肤科将医学置于医疗必需品和患者愿望之间的紧张境地。美学问题与皮肤科最为相关,因为皮肤不仅是心脏、肝脏和肾脏等功能器官,也是视觉和触觉交流的媒介。因此,患者寻求改善外貌和容貌的建议时,常常会表达对美丽和年轻的渴望。

由于需求增加,肉毒杆菌、真皮填充剂和激光手术等美容手术现在在制药行业和医疗器械行业非常受欢迎。美容治疗使用不同的技术、设备和程序,但非手术或非侵入性和微创方法已变得流行,因为患者群体中并发症和副作用较少。

Data Bridge Market Research分析,2022年至2029年的预测期内,全球美容皮肤科市场将以10.2%的复合年增长率增长。

报告指标

细节

预测期

2022 至 2029 年

基准年

2021

历史岁月

2020(可定制 2019-2014)

定量单位

收入(百万美元)、销量(单位)、定价(美元)

涵盖的领域

Product Type (Medicines and Devices), Surgery Type (Minimally Invasive and Non-Invasive), Treatment Type (Face Treatment and Body Treatment), Application (Skin Rejuvenation, Skin Resurfacing, Skin Tightening, Hair Removal, Pigmented & Vascular Lesions, Tattoo Removal, Scar, Acne, Dyschromia, Skin Tags, Psoriasis, Warts, Hyperhidrosis, Moles and Freckles and Others), Gender (Female and Male), End User (Hospitals, Dermatology Clinics, Surgical Centres, Spa Clinics and Others), Distribution Channel (Direct Tender and Retail Sales)

Countries Covered

U.S., Canada and Mexico in North America Germany, U.K., France, Spain, Italy, Netherlands, Switzerland, Russia, Turkey, Hungary, Poland, Austria, Ireland, Norway, Lithuania and Rest of Europe in Europe China, Japan, India, South Korea, Australia, Thailand, Malaysia, Singapore, Indonesia, Philippines, Vietnam and Rest of Asia-Pacific in Asia-Pacific South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and Rest of Middle East and Africa in Middle East and Africa Brazil, Argentina, Peru and Rest of South America in South America

Market Players Covered

AbbVie Inc. (U.S.), Henry Schein, Inc. (U.S.), Merz Pharma (Germany), Cutera (U.S.), Cynosure. Inc. (A Subsidiary of Hologic, Inc.) (U.S.), Candela Medical (U.S.), Bausch Health Companies Inc. (Canada), Evolus, Inc. (U.S.), Medytox (South Korea), LUTRONIC (South Korea), HUGEL, Inc. (South Korea), El. En. S.p.A. (Italy), Hoahai Biological Technology (China), REVANCE THERAPEUTICS (U.S.), Lumenis Be Ltd. (Israel), Venus Concept (Canada), Alma Lasers (Israel), Fotona (Slovenia), Aesthetic Biomedical (U.S.), ThermiGen, LLC. (U.S.), R2 TECHNOLOGIES, INC. (A Subsidiary of INNOVATE Corp.) (U.S.), Sensus Healthcare, Inc. (U.S.), Aesthetic Technology Limited (U.K.), DELEO (France), Biotech Italia Srl (France), Medency (Italy), Aerolase Corp. (U.S.), Sciton (U.S.), Image Derm, Inc. (U.S.) and PhotoMedex (U.S.)

Aesthetic Dermatology Market Dynamics

Drivers

  • Growing desire to improve one's appearance

The rising influence of the fashion industry and the desire to achieve a flawless body shape is a factor bolstering the growth of the aesthetic dermatology market. Thus, the growing desire to improve one's appearance is expected to act as a driver for the growth of the global aesthetic dermatology market in the forecasted period.

  • Rise in preference for minimally invasive and non-invasive procedures

With rising technological advancements and communications over to this digital world, people are more aware of aesthetic devices and procedures that are well performed in healthcare, impacting the adoption of minimally invasive procedures positively in the upcoming era. Thus, the increasing prevalence of minimally invasive procedures is expected to drive growth in the global aesthetic dermatology market.

美容皮肤科市场增长

Opportunities

  • Strategic initiatives by market players

In October 2020, Abbvie Inc. announced that it had agreed with Luminera, a privately held; Aesthetics Company based in Israel with a portfolio and pipeline of dermal filler products

These strategic initiatives taken by the market players, including focused segment product launches, are helping them to expand their Global reach and enhance their product portfolio and hence acting as opportunity for the growth of the market.

  • Decreased disparity between men and women for aesthetic procedures

Earlier aesthetic procedures were only limited to women, but this point of view has been altered as the males are equally conscious of the way they look. Submental fullness bothers men as well as women. The popularity of several other procedures (both surgical & non-surgical) is also increasing among men. Hence the decreasing disparity between men and women with growing modernization has opened the market for new male clientele; therefore, it is an opportunity for the market.

Restraints/Challenges

  • Lack of skilled professionals

Aesthetic treatment procedures consist of different medicines and laser based technologies, among others. All such techniques need qualified interpersonal skills to carry out effective treatment. As skill demands are too high, this has become difficult to address by skilled professionals, which acts as a challenge for carrying out the aesthetic procedure.

This aesthetic dermatology market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on lissencephaly treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Post COVID-19 Impact on Aesthetic Dermatology Market

The COVID-19 has negatively affected the market. Lockdowns and isolation during pandemics complicate the aesthetic management and medication adherence. The lack of access to health-care facilities for routine treatment and medication administration will further affect the market. Social isolation increases stress, despair, and social support, all of which may cause a reduction in aesthetic procedures during the pandemic.

Recent Development

  • In April 2021, Alma Lasers announced the launch of new Alma Prime X platform. The Alma Prime X gives result in circumference reduction and skin tightening in the abdomen, thighs, waist and buttock area. This has helped the company to increase its portfolio

Aesthetic Dermatology Market Scope

The Aesthetic dermatology market is categorized into seven notable segments based on product type, surgery type, treatment type, application, gender, end user, and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

  • Medicines
  • Devices

Based on products type, the global aesthetic dermatology market is segmented into medicines and devices.

Surgery Type

  • Minimally Invasive
  • Non-Invasive

Based on surgery type, the global aesthetic dermatology market is segmented into minimally invasive and non-invasive.

Treatment Type

  • Face Treatment
  • Body Treatment

Based on treatment type, the global aesthetic dermatology market is segmented into face treatment and body treatment.

Application

  • Skin Rejuvenation
  • Skin Resurfacing
  • Skin Tightening
  • Hair Removal
  • Pigmented & Vascular Lesions
  • Tattoo Removal
  • Scar
  • Acne
  • Dyschromia
  • Skin Tags
  • Psoriasis
  • Warts
  • Hyperhidrosis
  • Moles And Freckles
  • Others

Based on application, the global aesthetic dermatology market is segmented into skin rejuvenation, skin resurfacing, skin tightening, hair removal, pigmented & vascular lesions, tattoo removal, scar, acne, dyschromia, skin tags, psoriasis, warts, hyperhidrosis, moles and freckles and others.

Gender

  • Female
  • Male

Based on gender, the global aesthetic dermatology market is segmented into female and male.

End User

  • Hospitals
  • Dermatology Clinics
  • Surgical Centres
  • Spa Clinics
  • Others

Based on end user, the global aesthetic dermatology market is segmented into hospitals, dermatology clinics, surgical centres, spa clinics and others.

Distribution Channel

  • Direct Tender
  • Retail Sales

美容皮肤科市场预测

Based on distribution channel, the global aesthetic dermatology market is segmented into direct tender and retail sales.

Aesthetic Dermatology Market Regional Analysis/Insights

The aesthetic dermatology market is analysed and market size insights and trends are provided by country, product type, surgery type, treatment type, application, gender, end user and distribution channel as referenced above.

The countries covered in the global aesthetic dermatology market report are U.S., Canada and Mexico in North America Germany, U.K., France, Spain, Italy, Netherlands, Switzerland, Russia, Turkey, Hungary, Poland, Austria, Ireland, Norway, Lithuania and rest of Europe in Europe China, Japan, India, South Korea, Australia, Thailand, Malaysia, Singapore, Indonesia, Philippines, Vietnam and rest of Asia-Pacific in Asia-Pacific South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and rest of Middle East and Africa in Middle East and Africa Brazil, Argentina, Peru and rest of South America in South America.

就市场份额和市场收入而言,北美在美容皮肤科市场占据主导地位,并将在预测期内继续保持主导地位。这是因为该地区拥有主要的关键参与者和发达的医疗保健基础设施。另一方面,由于患者数量不断增加、医疗保健行业投资不断增加以及政府支持不断增加,预计亚太地区在预测期内的增长率最高。

美容皮肤科市场分析

报告的国家部分还提供了影响单个市场因素和国内市场法规变化,这些变化影响了市场的当前和未来趋势。新销售、替代销售、国家人口统计、疾病流行病学和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外,在对国家数据进行预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、销售渠道的影响。

美容皮肤科市场份额分析

美容皮肤科市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、沙特阿拉伯业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对美容皮肤科市场的关注有关。

全球美容皮肤科市场的一些主要公司包括 AbbVie Inc.、Henry Schein, Inc.、Merz Pharma、Cutera、Cynosure. Inc. (Hologic, Inc. 的子公司)、Candela Medical、Bausch Health Companies Inc.、Evolus, Inc.、Medytox、LUTRONIC、HUGEL, Inc.、El. En. SpA、Hoahai Biological Technology、REVANCE THERAPEUTICS、Lumenis Be Ltd.、Venus Concept、Alma Lasers、Fotona、Aesthetic Biomedical、ThermiGen, LLC.、R2 TECHNOLOGIES, INC. (INNOVATE Corp. 的子公司)、Sensus Healthcare, Inc.、Aesthetic Technology Limited、DELEO、Biotech Italia Srl、Medency、Aerolase Corp.、Sciton、Image Derm, Inc. 和 PhotoMedex 等。


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The new sales, replacement sales, country demographics, disease epidemiology and import-export tariff are the major data pointers of the Aesthetic Dermatology Market.
The Aesthetic Dermatology Market growth rate will be 10.2% by 2029.
The Growing desire to improve one's appearance and Rise in preference for minimally invasive and non-invasive procedures are the growth drivers of the Aesthetic Dermatology Market.
The product type, surgery type, treatment type, application, gender, end user, and distribution channel are the factors on which the Aesthetic Dermatology Market research is based.
The major companies in the Aesthetic Dermatology Market are AbbVie Inc., Henry Schein, Inc., Merz Pharma, Cutera, Cynosure. Inc. (A Subsidiary of Hologic, Inc.), Candela Medical, Bausch Health Companies Inc., Evolus, Inc., Medytox, LUTRONIC, HUGEL, Inc., El. En. S.p.A., Hoahai Biological Technology, REVANCE THERAPEUTICS, etc.